Literature DB >> 81772

Long term antithyroid drug therapy for intractable cases of Graves' disease.

K Shizume.   

Abstract

Among the 504 patients with Graves' disease in whom the author initiated antithyroid drug therapy between 1956 and 1968 are 14 to whom the administration of antithyroid drug has been continued for 8 to 21 years because of recurrence shortly after the discontinuation of drugs. During these periods, no side effects were observed and three patients went into complete remission after 8, 9 and 20 years of antithyroid drug administration, respectively. It is suggested therefore that the long term administration of antithryoid drugs can be a useful treatment for intractable cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81772     DOI: 10.1507/endocrj1954.25.377

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

Review 1.  Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.

Authors:  F Azizi; H Abdi; L Mehran; A Amouzegar
Journal:  J Endocrinol Invest       Date:  2022-01-28       Impact factor: 4.256

2.  A second course of antithyroid drug therapy for recurrent Graves' disease: an experience in endocrine practice.

Authors:  Xiaomei Liu; Wei Qiang; Xingjun Liu; Lianye Liu; Shu Liu; Aibo Gao; Shan Gao; Bingyin Shi
Journal:  Eur J Endocrinol       Date:  2014-12-02       Impact factor: 6.664

3.  Long-term monitoring of Graves’ disease in children and adolescents: a single-centerzzm321990experience

Authors:  Selma Tunç; Özge Köprülü; Hatice Ortaç; Özlem Nalbantoğlu; Ceyhun Dizdarer; Korcan Demir; Behzat Özkan
Journal:  Turk J Med Sci       Date:  2019-04-18       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.